Biotech

All Articles

BioAge eyes $180M from IPO, personal placement for obesity trials

.BioAge Labs is actually checking out all around $180 million in preliminary proceeds coming from an...

Merck's LAG-3 combination falls short intestines cancer phase 3 research study

.An effort through Merck &amp Co. to unlock the microsatellite steady (MSS) metastatic colorectal ca...

Spanish VC closes $200M life sciences fund

.Spain-based Asabys Partners has closed a fund of 180 thousand euros ($ 200 million), loan that will...

BioAge generates $198M from IPO as excessive weight biotech signs up with Nasdaq

.BioAge Labs is actually generating almost $200 million by means of its own Nasdaq IPO today, along ...

Acadia brings BMS vet on board as CEO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as ...

Cassava pays $40M over supposedly deceiving Alzheimer's upgrade

.Cassava Sciences has actually consented to pay for $40 thousand to address an investigation right i...

Merck bags possibilities on Evaxion's AI-designed vaccine candidates

.Merck &amp Co. has actually grabbed alternatives on two Evaxion Biotech vaccination candidates, pay...

Enanta's RSV antiviral crushes viral tons in challenge research study

.Enanta Pharmaceuticals has linked its respiratory syncytial virus (RSV) antiviral to notable reduct...

Biogen containers SAGE-324 collaboration after necessary agitation fail

.Biogen has actually carried out the last rites to its own collaboration with Sage Therapies on SAGE...

AbbVie Parkinson's medication from $8.7 B Cerevel buyout scores

.On the same day that some Parkinson's health condition medications are actually being questioned, A...